U.S. Markets closed

Strength Seen in Aegerion Pharmaceuticals, Inc. (AEGR): Stock Shoots up 16.4%

Zacks Equity Research

Aegerion Pharmaceuticals, Inc. (AEGR) was a big mover last session, as the company saw its shares surge over 16% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session This broke the recent trend of the company, as the stock is now trading above the volatile price range of $26.9 to $32.7 in the past one-month time frame.

Although the company has seen no estimate revisions in the past one month, its Zacks Consensus Estimate of a loss widened over the same period, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

Aegerion Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other attractive players in the med-biomed industry include Actelion Ltd. (ALIOF) and Illumina Inc. (ILMN),  carrying a Zacks Rank #1 (Strong Buy) and Enzo Biochem Inc. (ENZ) with a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 DaysClick to get this free report >>


ACTELION LTD (ALIOF): Free Stock Analysis Report

ENZO BIOCHEM INC (ENZ): Free Stock Analysis Report

ILLUMINA INC (ILMN): Free Stock Analysis Report

Zacks Investment Research